US stocks have surged | Parabilis Medicines (PBLS.US) makes its debut on the US stock market with a price increase of over 44% after opening.

According to the Securities Times app, on Wednesday, the American biotechnology company Parabilis Medicines (PBLS.US) that focuses on cancer treatment, made its debut on the US stock market. The stock price rose at the opening, and as of the time of writing, it has increased by 44.35% to $28.87. The IPO price was $20. Parabilis was founded in 2015 and focuses on developing treatment options for various cancers and rare tumors. The company plans to use the funds raised from the IPO to advance its leading candidate drug, zolucatetide, into later-stage clinical trials.